<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03906032</url>
  </required_header>
  <id_info>
    <org_study_id>UHWHip#</org_study_id>
    <nct_id>NCT03906032</nct_id>
  </id_info>
  <brief_title>Comparison of Sliding Hip Screw to Intra Medullary Nailing in the Treatment of Intertrochanteric Hip Fracture</brief_title>
  <official_title>Prospective Randomized Controlled Comparison of Sliding Hip Screw to Intra Medullary Nailing in the Treatment of Intertrochanteric Hip Fracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Waterford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DePuy Synthes</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Waterford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Shortening of the abductor lever arm is a particular concern with the SHS, and the resultant
      biomechanical alterations impairs gait, including decreased cadence and increased double
      support time on the injured side.

      The use of a IM nail device may stop this shortening and improve functional parameters in
      this patient cohort
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Published work in this field to date has not demonstrated a clear advantage of nailing over
      hip screw in intertrochanteric proximal femoral fractures. The current lierature focus on
      outcome questionnaires, pain scores and basic functional tests alone does not delineate the
      functional benefits clearly enough. A key factor in whether a person, post hip fracture,
      returns to independent living is gait speed. The cost implications on the healthcare provider
      of having 30% of this ever increasing group losing their independence and requiring admission
      to a care facility post hip fracture is a growing problem.

      Shortening of the abductor lever arm is a particular concern with the SHS, and the resultant
      biomechanical alterations impairs gait, including decreased cadence and increased double
      support time on the injured side.

      The difference in cost between a nail and a SHS is a driver to prevent routine use of nailing
      in this population unless a clear benefit is demonstrated. Fracture union is not a problem
      for the most part and, as such, the focus must be on achieving better functional outcome,
      less morbidity and less mortality in this group.

      The key question to answer is whether a IM Nail (TFNA) results in a greater functional
      benefit in A1/A2 intertrochanteric fractures compared with the SHS.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2019</start_date>
  <completion_date type="Anticipated">April 2, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>Mathematical model Day 2 Hb</time_frame>
    <description>Haemaglobin (Hb) day two measurement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood Loss</measure>
    <time_frame>Mathematical model Day 2 Hct</time_frame>
    <description>Haematocrit (Hct) at day two measurement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>At any time point to 1 year post op</time_frame>
    <description>Absolute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analgesia Use</measure>
    <time_frame>5 days</time_frame>
    <description>rate of opiate use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Timed up and go test</measure>
    <time_frame>6 weeks, 6 months, 1 year</time_frame>
    <description>Tested measure of mobility and the change between baseline and subsequent time points</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Harris Hip score</measure>
    <time_frame>6 weeks, 6 months, 1 year</time_frame>
    <description>Functional scale of hip pain and the change between baseline and subsequents time points. Maximum score: 100 points indicating excellent function, minimum score 0 points indicating poor function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kinmeatic Gait parameters at Hip</measure>
    <time_frame>6 weeks, 6 months, 1 year</time_frame>
    <description>Rate of change in hip kinmeatic profile between baseline and subsequent time points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>Through to study completion at one year post operatively.</time_frame>
    <description>the duration of hospital stay after this procedure has wide variability between 3 days and weeks to months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">352</enrollment>
  <condition>Hip Fractures</condition>
  <condition>Gait, Unsteady</condition>
  <condition>Function</condition>
  <arm_group>
    <arm_group_label>Intra-medullary hip Nail</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sliding hip screw</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TFNA IM Nail</intervention_name>
    <description>IM nail</description>
    <arm_group_label>Intra-medullary hip Nail</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sliding hip screw</intervention_name>
    <description>SHS surgical fixation</description>
    <arm_group_label>Sliding hip screw</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OTA Hip fracture grade A1 and A2

          -  Greater than 60 years old

        Exclusion Criteria:

          -  Polytrauma, high-energy hip fractures, pathological fractures,

          -  Reverse oblique and sub-trochanteric femoral fractures

          -  less than 60 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>May Cleary, FRCS</last_name>
    <phone>0035351848000</phone>
    <email>may.cleary@hse.ie</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Waterford</name>
      <address>
        <city>Waterford</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>May Cleary</last_name>
      <phone>0035351848000</phone>
      <email>may.cleary@hse.ie</email>
    </contact>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>April 1, 2019</study_first_submitted>
  <study_first_submitted_qc>April 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2019</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Waterford</investigator_affiliation>
    <investigator_full_name>Enda Kelly</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Timed up and go</keyword>
  <keyword>mobility</keyword>
  <keyword>functional outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

